IBM
IBM's Q2 2026, reported July 22, put revenue at $16.5B (+6.5% YoY) with software at $6.8B (+8.5%), ahead of the $16.2B consensus. The widely-quoted $12.5B genAI "book of business" is a cumulative inception-to-date bookings total disclosed with Q4 2025 results - roughly $2B software and $10.5B consulting - not a quarterly figure; earlier summaries here conflated the two and that is corrected. Think 2026 (May 5) remains the most recent product milestone, delivering watsonx Orchestrate for multi-agent orchestration and Sovereign Core GA. Nothing AI-specific dated after July 25 surfaced this cycle.
Scenarios
Doubled genAI bookings and Sovereign Core GA create two distinct growth vectors (enterprise AI + regulated/sovereign markets) that competitors lack. If consulting stabilizes around 4-6% while software sustains 10%+, the mix shift strengthens the overall AI impact score.
Consulting fee compression from AI remains structural. $61.3B debt limits reinvestment speed. One-quarter revenue beat does not resolve long-term consulting disruption risk.
Key Factors to Watch
- ●GenAI "book of business" of $12.5B is a CUMULATIVE inception-to-date bookings total (~$2B software, ~$10.5B consulting) disclosed with Q4 2025 results — not a quarterly figure; do not restate it as quarterly growth
- ●watsonx Code Assistant for Z clients growing MIPS capacity 3x faster than non-users — mainframe AI monetization is working
- ●IBM Sovereign Core (GA) addresses EU/APAC/ME data-sovereignty gap — meaningful TAM differentiation for regulated markets
- ●FedRAMP expansion: watsonx portfolio grew from 3 to 11 authorized solutions in one year — federal AI footprint quadrupled
- ●Consulting +4% YoY — not declining but growing slowly as AI tools compress deal sizes vs. software's 11% growth
Score History
| Date | Score | Direction | Note |
|---|---|---|---|
| 2026-05-16 | 6.4 | Positive | W20 refresh — score 6.1→6.4 (are 6→7). Q1 FY26: revenue $15.9B +9.5%, genAI bookings doubled, software 40%+ of mix. Think 2026: Sovereign Core GA, FedRAMP quadrupled to 11. |
| 2026-03-08 | 6.1 | Positive | Score 6.2→6.1 (reweight + dr 6→5). dr corrected: $12.5B GenAI book of business, $4.5B internal AI savings, Watsonx pipeline |
| 2026-03-08 | 6.2 | Positive | Score 5.1->6.2 (are 5->6, md 5->6, dr 8->6, aam 6->8). External research cross-ref: dramatically underscored — $12.5B GenAI book, Project Bob 45% productivity, $4.5B internal savings, $14.7B FCF, z17 +67% |
| 2026-03-08 | 5.1 | Neutral | Initial assessment from batch 1 research |
Consulting Peers
Last researched: 2026-09-12
This is research and analysis, not financial advice. Scores reflect AI impact potential, not investment recommendations.